{
  "id": "530cf4fe960c95ad0c000007",
  "type": "list",
  "question": "What are the indications for hydrochlorothiazide?",
  "ideal_answer": "Hydrochlorothiazide is a diuretic, often used in combination with others. Hydrochlorothiazide are used to treat hypertension. Hydrochlorothiazide has been shown to decrease diastolic blood pressure.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23808745",
    "http://www.ncbi.nlm.nih.gov/pubmed/21974759",
    "http://www.ncbi.nlm.nih.gov/pubmed/23116225",
    "http://www.ncbi.nlm.nih.gov/pubmed/9421695",
    "http://www.ncbi.nlm.nih.gov/pubmed/23136355",
    "http://www.ncbi.nlm.nih.gov/pubmed/8227469",
    "http://www.ncbi.nlm.nih.gov/pubmed/23767455",
    "http://www.ncbi.nlm.nih.gov/pubmed/21718097",
    "http://www.ncbi.nlm.nih.gov/pubmed/22490507"
  ],
  "snippets": [
    {
      "text": "The most frequently used diuretic in combination is again hydrochlorothiazide, which is combined with reninangiotensin system blockers",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23808745",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Also a combination of two diuretics is popular -\u200a mainly hydrochlorothiazide + amiloride",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23808745",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "article gives an overview of the risk factors for hypertension and the appropriate indication for using a fixed combination of telmisartan and hydrochlorothiazide",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23767455",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hydrochlorothiazide 25-200 mg daily, chlorothiazide 500 mg twice daily, and indapamide 2.5 mg daily provided long-term blood pressure reduction in patients with severe renal disease who were not on dialysis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23136355",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This review provides an overview of the efficacy and safety of antihypertensive therapy based on olmesartan medoxomil\u2009\u00b1\u2009hydrochlorothiazide and amlodipine/olmesartan medoxomil in high-risk patient populations enrolled in studies that reported ambulatory BP endpoints",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23116225",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In this regard, ARB-based SPCs are available in combination with the diuretic, hydrochlorothiazide (HCTZ) or the calcium CCB, amlodipine",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22490507",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Telmisartan has a favourable safety and tolerability profile, and has demonstrated efficacious and long-lasting 24-hour BP reductions, whether as monotherapy or in combination with hydrochlorothiazide or amlodipine",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21718097",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The combination of irbesartan and hydrochlorothiazide resulted in additive antihypertensive effects",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9421695",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Patients with stable hypertension, not taking antihypertensive or NSAID medications, were treated with HCTZ 50 mg/day",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8227469",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "is study determined the effect of nonsteroidal anti-inflammatory drug (NSAID) administration on blood pressure in hypertensive patients taking hydrochlorothiazide (HCTZ). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8227469",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hydrochlorothiazide treatment decreased diastolic blood pressure to 83.1 +/- 5.6 mm Hg, and MAP to 101.1 +/- 6.5 mm Hg",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8227469",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21974759",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This 16-week trial investigated the efficacy and safety of single-pill valsartan/hydrochlorothiazide (HCTZ) vs. the individual components in patients 70years and older with systolic hypertension.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21974759",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The article gives an overview of the risk factors for hypertension and the appropriate indication for using a fixed combination of telmisartan and hydrochlorothiazide",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23767455",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.biosemantics.org/jochem#4249423",
    "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006852"
  ],
  "exact_answer": "diuretic, hypertension"
}